Thanks DG for posts, and others, Damaj is a science guy, not a seasoned CEO for commercializing a co. I think the co is entering the next chapter, may be some more delay but's that's par for the course with bio-techs. They really need to provide clarity on status of catalysts at this point. Where's the PR for the call damn it.